Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Shares of major U.S. companies in the energy sector are sharply higher after President Donald Trump announced plans to take ...
Also highlight plans to integrated with Biocon at 44th Annual J.P. Morgan Healthcare Conference in San Francisco ...
He will also participate in a fireside chat at the ENDPOINTS at JPM26 conference on Tuesday, January 13 titled, "Achieving ...
In a recent J.P. Morgan podcast on retail versus institutional investor behavior, the bank’s research team noted that retail ...
J.P. Morgan said on Monday it launched a new advisory unit to serve a select group of clients and widen their access to ...
JPMorgan Chase (JPM) on Monday launched a new advisory unit for top-tier clients to expand beyond traditional M&A and ...
JPMorgan tokenizes cash with its MONY fund on Ethereum, signaling how Wall Street is reshaping money, settlement, and the ...
Top Isa rates above 4 per cent may not be available for long in 2026, according to savings experts. James Blower, founder of ...
JPMorgan Chase froze accounts linked to two Y Combinator-backed stablecoin startups after detecting exposure to Venezuela, a ...
JPMorgan froze stablecoin startup accounts over compliance risks, highlighting growing pressure on banks as regulations ...
Articles about stablecoins, scams, fintechs, premium credit cards, and open banking were just some of the topics that struck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback